Back to search

Article

The oncogenic CCDC6-RET fusion product is a dual ATP and ADP-dependent kinase that functions via <i>cis</i> -phosphorylation

2025-01-16

Abstract excerpt

<h4>Summary</h4> Gene fusions products involving protein kinases are known drivers in human cancers and actionable targets for personalized therapy, yet the structural and molecular determinants that control their function are largely unexplored. Here we show that a CCDC6-RET fusion product, a driver and therapeutic target in lung and thyroid cancers, is a highly active dimeric kinase in solution. Time-resolved m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2217c037-f1e3-5adb-8664-6d82732eb823
DOI
10.1101/2025.01.14.632894
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The oncogenic CCDC6-RET fusion product is a dual ATP and ADP-dependent kinase that functions via <i>cis</i> -phosphorylationDOI 10.1101/2025.01.14.632894
Select a neighboring publication to make it the new centre.